4//SEC Filing
Mulroy Michael H. 4
Accession 0001493152-21-014860
CIK 0000876343other
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 4:15 PM ET
Size
18.0 KB
Accession
0001493152-21-014860
Insider Transaction Report
Form 4
Mulroy Michael H.
Director
Transactions
- Exercise/Conversion
Common Shares, no par value
2021-06-18$2.20/sh+24,720$54,384→ 251,555 total - Exercise/Conversion
Stock Option (right to buy)
2021-06-18−24,720→ 0 totalExercise: $2.20Exp: 2021-06-30→ Common Shares (24,720 underlying)
Footnotes (1)
- [F1]This option became exercisable in four equal quarterly installments after the date of grant on July 1, 2016.
Documents
Issuer
Lineage Cell Therapeutics, Inc.
CIK 0000876343
Entity typeother
Related Parties
1- filerCIK 0001509725
Filing Metadata
- Form type
- 4
- Filed
- Jun 20, 8:00 PM ET
- Accepted
- Jun 21, 4:15 PM ET
- Size
- 18.0 KB